These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Cancer of therapeutic origin]. Belpomme D; Blondel P; Mathe G Vie Med Can Fr; 1972 Feb; 1(2):140-50. PubMed ID: 4637392 [No Abstract] [Full Text] [Related]
23. [Is it possible to predict leukemias induced by radiotherapy or chemotherapy?]. Boivin P Nouv Presse Med; 1978 Sep; 7(29):2533-4. PubMed ID: 704312 [No Abstract] [Full Text] [Related]
25. Second primary cancer due to radiotherapy and chemotherapy. Manavoğlu O; Orhan B; Evrensel T; Karabulut Y; Ozkocaman V; Ozyardimci C J Environ Pathol Toxicol Oncol; 1996; 15(2-4):275-8. PubMed ID: 9216821 [TBL] [Abstract][Full Text] [Related]
26. A multidisciplinary approach to identification and remedial intervention for adverse late effects of cancer therapy. McCalla JL Nurs Clin North Am; 1985 Mar; 20(1):117-30. PubMed ID: 3844813 [TBL] [Abstract][Full Text] [Related]
27. [Leukemia in patients with breast carcinoma after adjuvant chemotherapy and/or postoperative radiotherapy]. Sack H Strahlenther Onkol; 1995 Jul; 171(7):420-1. PubMed ID: 7631268 [No Abstract] [Full Text] [Related]
28. Late effects of cancer therapy: chemotherapy-related malignancies. Fraser MC; Tucker MA Oncol Nurs Forum; 1988; 15(1):67-77. PubMed ID: 3278303 [No Abstract] [Full Text] [Related]
29. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer. Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192 [TBL] [Abstract][Full Text] [Related]
30. Second neoplasm--a complication of cancer chemotherapy. Chabner BA N Engl J Med; 1977 Jul; 297(4):213-5. PubMed ID: 876277 [No Abstract] [Full Text] [Related]
31. Secondary neoplasms in patients treated for cancer: etiology and perspective. Coleman CN Radiat Res; 1982 Oct; 92(1):188-200. PubMed ID: 7134383 [No Abstract] [Full Text] [Related]
32. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202 [TBL] [Abstract][Full Text] [Related]
33. Hodgkin's disease: treatment and secondary neoplasms. Kaiser HE In Vivo; 1994; 8(5):733-6. PubMed ID: 7727720 [TBL] [Abstract][Full Text] [Related]
34. Estimation of cancer risks from radiotherapy of benign diseases. Trott KR; Kamprad F Strahlenther Onkol; 2006 Aug; 182(8):431-6. PubMed ID: 16896588 [TBL] [Abstract][Full Text] [Related]
35. Leukemia, lymphoma, and multiple myeloma after pelvic radiotherapy for benign disease. Inskip PD; Kleinerman RA; Stovall M; Cookfair DL; Hadjimichael O; Moloney WC; Monson RR; Thompson WD; Wactawski-Wende J; Wagoner JK Radiat Res; 1993 Jul; 135(1):108-24. PubMed ID: 8327655 [TBL] [Abstract][Full Text] [Related]